Francesco Scopinaro

Francesco Scopinaro

Auto-generated profile, based on publicly available information

Francesco Scopinaro

Sant’Andrea Hospital

Research Focus & Metrics

Academic Career Length

45Years (1982-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 August 2014 in European Journal of Nuclear Medicine and Molecular Imaging
Verified
Journal Article
Closed access
PDF file
Francesco CiconeFrancesco Cicone
Francesco Cicone
Giuseppe MinnitiGiuseppe Minniti
Giuseppe Minniti
ARAndrea Romano
Andrea Romano
APAnnalisa Papa
Annalisa Papa
CSClaudia Scaringi
Claudia Scaringi
FSFrancesco Scopinaro
Francesco Scopinaro

1 September 1994 in European Journal of Nuclear Medicine and Molecular Imaging
Verified
Journal Article
Closed access
PDF file
FSF. Scopinaro
F. Scopinaro
OSOrazio Schillaci
Orazio Schillaci
MSM. Scarpini
M. Scarpini
PMP. L. Mingazzini
P. L. Mingazzini
LML. Di Macio
L. Di Macio
ACA. Centi Colella
A. Centi Colella

1 June 1998 in Gut
Verified
Journal Article
Open access
PDF file
SAS Angeletti
S Angeletti
VCV D Corleto
V D Corleto
OSOrazio Schillaci
Orazio Schillaci
MMM Marignani
M Marignani
BABruno Annibale
Bruno Annibale
GFG Delle Fave
G Delle Fave
Background —Somatostatin receptor scintigraphy (SRS) and octreotide therapy have both changed the management of gastroenteropancreatic endocrine tumours, but very few data are available on the use of SRS and octreotide to visualise and treat somatostatinomas. Method —The results of SRS and octreotide treatment in three somatostatinoma patients were examined. Results —SRS was able to detect extensive hepatic involvement in patient 1, one hepatic and one pancreatic lesion in patient 2, and one hepatic lesion in patient 3. Octreotide therapy (0.5 mg/day subcutaneously) was effective in decreasing plasma levels of somatostatin in all three patients. Symptoms (diabetes and diarrhoea) were greatly improved in the two patients with “somatostatinoma syndrome”. Conclusion —The study shows that somatostatinoma, like most other gastroenteropancreatic endocrine tumours, possesses functioning somatostatin receptors.

12 October 1999 in European Journal of Nuclear Medicine and Molecular Imaging
Verified
Journal Article
Closed access
PDF file
FSFrancesco Scopinaro
Francesco Scopinaro
RPRoberto Pani
Roberto Pani
GVGiuseppe De Vincentis
Giuseppe De Vincentis
ASAlessandro Soluri
Alessandro Soluri
RPRosanna Pellegrini
Rosanna Pellegrini
LPLucio M. Porfiri
Lucio M. Porfiri

16 June 2011 in Journal of Nuclear Medicine
Verified
Journal Article
Closed access
PDF file
DFDemetrio Familiari
Demetrio Familiari
Andor W. J. M. GlaudemansAndor W. J. M. Glaudemans
Andor W. J. M. Glaudemans
VVValeria Vitale
Valeria Vitale
DPDaniela Prosperi
Daniela Prosperi
OBOreste Bagni
Oreste Bagni
Alberto SignoreAlberto Signore
Alberto Signore
White blood cell (WBC) scintigraphy is considered the nuclear medicine imaging gold standard for diagnosing osteomyelitis in the diabetic foot. Recent papers have suggested that the use of 18F-FDG PET/CT produces similar diagnostic accuracy, but clear interpretation criteria have not yet been established. Our aim was to evaluate the role of sequential 18F-FDG PET/CT in patients with a high suspicion of osteomyelitis to define objective interpretation criteria to be compared with WBC scintigraphy. Methods: Thirteen patients whom clinicians considered positive for osteomyelitis (7 with ulcers, 6 with exposed bone) were enrolled. The patients underwent 99mTc-exametazime WBC scintigraphy with acquisition times of 30 min, 3 h, and 20 h and sequential 18F-FDG PET/CT with acquisition times of 10 min, 1 h, and 2 h. A biopsy or tissue culture was performed for final diagnosis. Several interpretation criteria (qualitative and quantitative) were tested. Results: At final biopsy, 7 patients had osteomyelitis, 2 had soft-tissue infection without osteomyelitis, and 4 had no infection. The best interpretation criterion for osteomyelitis with WBC scintigraphy was a target-to-background (T/B) ratio greater than 2.0 at 20 h and increasing with time. A T/B ratio greater than 2.0 at 20 h but stable or decreasing with time was suggestive of soft-tissue infection. A T/B ratio of no more than 2.0 at 20 h excluded an infection. Thus, sensitivity, specificity, positive predictive value, negative predictive value, and accuracy for osteomyelitis were 86%, 100%, 100%, 86%, and 92%, respectively. For 18F-FDG PET/CT, the best interpretation criterion for osteomyelitis was a maximal standardized uptake value (SUVmax) greater than 2.0 at 1 and 2 h and increasing with time. A SUVmax greater than 2.0 after 1 and 2 h but stable or decreasing with time was suggestive of a soft-tissue infection. An SUVmax less than 2.0 excluded an infection. 18F-FDG PET at 10 min was not useful. Using these criteria, sensitivity, specificity, positive predictive value, negative predictive value, and accuracy for osteomyelitis were 43%, 67%, 60%, 50%, and 54%, respectively. Combining visual assessment of PET at 1 h and CT was best for differentiating between osteomyelitis and soft-tissue infection, with a diagnostic accuracy of 62%. Conclusion: 18F-FDG PET/CT, even with sequential imaging, has a low diagnostic accuracy for osteomyelitis and cannot replace WBC scintigraphy in patients with diabetic foot.

1 April 1998 in Critical Care Medicine
Verified
Journal Article
Closed access
Luigi TritapepeLuigi Tritapepe
Luigi Tritapepe
GMGuido Macchiarelli
Guido Macchiarelli
Monica RoccoMonica Rocco
Monica Rocco
FSFrancesco Scopinaro
Francesco Scopinaro
OSOrazio Schillaci
Orazio Schillaci
PMPietro M. Motta
Pietro M. Motta
To study human myocardial ultrastructural changes after carbon monoxide (CO) poisoning inducing reversible cardiac failure. Case report: clinical, functional and morphologic findings. Public university-affiliated hospital and electron microscopy laboratory. A 25-yr-old woman with functional evidence of cardiac failure after acute CO poisoning. Hyperbaric and intensive care treatment over 10 days. Scintigraphic and cardiac angiography with endomyocardial biopsy. Scintigraphy with99m Tc hexakis 2-methoxy-2-isobutyl isonitrile (sestaMIBI) showed an uptake defect in the left anterior descending artery territory. The cardiac angiography demonstrated a slight hypokinesis of the superior two thirds of the anterior wall and of the septal region with completely normal coronary angiograms. Electron microscopy of left ventricular biopsies showed slight ultrastructural changes in the myocytes. In addition, large glycogen deposits were mostly associated with swollen mitochondria. The patient was discharged in good clinical condition on day 10. Presence of glycogen deposits associated with abnormal mitochondria may be signs of the incapability of myocardial cells in utilizing energy substrata. In the presence of normal myocardial perfusion, our findings are consistent with the presence of a stunned myocardium-like syndrome. Early recognition and treatment of this clinical syndrome allow the prevention of myocardial infarction. (Crit Care Med 1998; 26:797-801)